Prevalence and outcomes of end-stage kidney disease in patients with systemic lupus erythematous: a population-based study.
Journal Information
Full Title: Rheumatol Int
Abbreviation: Rheumatol Int
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Declarations Conflict of interestCL, PD, DW, KR, DF, AA, and RL declare that they have no conflict of interest. Ethical approvalEthics approval for the study was granted through the Northern B Health and Disability Ethics Committee (reference: 2022 EXP 13741). Conflict of interest CL, PD, DW, KR, DF, AA, and RL declare that they have no conflict of interest."
Funding Disclosure
Evidence found in paper:
"Funding Open Access funding enabled and organized by CAUL and its Member Institutions. This study is funded by Arthritis New Zealand (Lupus-SLE Postdoctoral Fellowship for Dr Chunhuan Lao)."
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025